TITLE

LUNG ALERT: Sensitivity of pulmonary function test in whether bronchodilatation is different in healthy subject and asthmatics

AUTHOR(S)
Menon, M.
PUB. DATE
October 2004
SOURCE
Thorax;Oct2004, Vol. 59 Issue 10, p875
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents information on sensitivity of pulmonary function tests in assessing whether bronchodilatation is different in healthy subjects and asthmatics. The ability of different pulmonary function tests to detect dose-response effects depends on both the variability and sensitivity of the methods used. In clinical trials bronchodilatation is usually assessed by spirometry. Researchers compared the sensitivity and variability of the above pulmonary function methods to measure the dose-response effects of salbutamol in both healthy subjects and asthmatics. The study involved 12 healthy subjects, 12 with mild asthma and 12 with moderate asthma. The most sensitive measurements were spirometry in healthy individuals and plethysmography in those with mild asthma.
ACCESSION #
14882958

 

Related Articles

  • External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Travers, Justin; Marsh, Suzanne; Williams, Mathew; Weatherall, Mark; Caidwell, Brent; Shirtcliffe, Philippa; Aldington, Sarah; Beasley, Richard // Thorax;Mar2007, Vol. 62 Issue 3, p219 

    Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a...

  • Inhaler Competence and Patient Satisfaction with Easyhaler: Results of Two Real-Life Multicentre Studies in Asthma and COPD. Gálffy, Gabriella; Mezei, Györgyi; Németh, Gyula; Tamási, Lilla; Müller, Veronika; Selroos, Olof; Orosz, Marta // Drugs in R&D;2013, Vol. 13 Issue 3, p215 

    Objective: The aim of this study was to investigate patients' inhaler competence and satisfaction with the Easyhaler dry powder inhaler. Design: Two open, uncontrolled, non-randomised studies. Setting: Real life based on patients attending 56 respiratory clinics in Hungary. Participants:...

  • Maria's review: all as expected? Dhami, Julie // Practice Nurse;4/10/2009, Vol. 37 Issue 7, p33 

    The article presents a case study of a 61-year-old woman with asthma. During her childhood, she required frequent hospitalizations for it. Her present medications are beclometasone by inhaler and salbutamol. The article discusses the results of spirometry testing, conditions that could cause the...

  • Early life origins of chronic obstructive pulmonary disease. C Svanes // Thorax;Jan2010, Vol. 65 Issue 1, p14 

    BACKGROUND: Early life development may influence subsequent respiratory morbidity. The impact of factors determined in childhood on adult lung function, decline in lung function and chronic obstructive pulmonary disease (COPD) was investigated. METHODS: European Community Respiratory Health...

  • Personalizovaná medicína chronické obÅ¡trukční pliení nemoci. V., KOBLIŽEK; J., CHLUMSKÝ; V., ZINDR; K., NEUMANNOVÁ; J., ZATLOUKAL; V., SEDLÁK; J., KOCIANOVÁ // General Practitioner / Prakticky Lekar;2013, Vol. 93 Issue 4, p169 

    Introduction: Chronic obstructive pulmonary disease (COPD) is a global problem with serious impacts on patients in the Czech Republic. The current view on COPD changes the diagnostic approach and optimal treatment recommendations. Methods: The Expert group of the Czech Pneumological and...

  • COPD 'spippery slope' slowed by long-acting β2-agonists. Finch, Rob // Pulse;6/14/2004, Vol. 64 Issue 24, p16 

    Reports that patients with chronic obstructive pulmonary disease (COPD) can benefit from long-acting beta-2-agonists, even when their lung function appears to have declined irreversibly, according to research by William Man and colleagues at King's College Hospital in London, England. Reduction...

  • Can spirometric norms be set using pre- or post- bronchodilator test results in older people? Kato, Bernet; Gulsvik, Amund; Vollmer, William; Janson, Christer; Studnika, Michael; Buist, Sonia; Burney, Peter // Respiratory Research;Nov2012, Vol. 13 Issue 11, p1 

    Background: Chronic Obstructive Pulmonary Disease (COPD) is defined by post-bronchodilator spirometry. Data on "normal values" come predominantly from pre-bronchodilator spirometry. The effects of this on diagnosis are unknown. Methods: Lower limits of normal (LLN) were estimated from "normal"...

  • Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Mannino, David M.; Diaz-Guzman, Enrique; Buist, Sonia // Respiratory Research;Oct2011, Vol. 12 Issue 10, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is supposed to be classified on the basis of postbronchodilator lung function. Most longitudinal studies of COPD, though, do not have post-bronchodilator lung function available. We used pre-and post bronchodilator lung function data from...

  • Broncodilatação na DPOC: muito além do VEF1--efeito do salbutamol nas propriedades resistivas e reativas do sistema respiratório. Da Costa, Gerusa Marítimo; Faria, Alvaro Camilo Dias; Tavares Di Mango, Ana Maria Gonçalves; Lopes, Agnaldo José; Jansen, José Manoel; De Melo, Pedro Lopes // Jornal Brasileiro de Pneumologia;apr2009, Vol. 35 Issue 4, p325 

    Objective: Current debates on the bronchodilator response in COPD patients and whether the variation in FEV1 can be considered as an indicator of complete reversibility in such patients motivated us to conduct this study. The objective of the study was to determine the effect of albuterol on the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics